Federal Home Loan Bank of San Francisco Announces Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
131
Federal Home Loan Bank of San Francisco Announces Annual and Quarterly Operating Results

SAN FRANCISCO, Feb. 21, 2017 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of San Francisco today announced its 2016 operating results. Net income for 2016 was $712 million, compared with net income of $638 million for 2015. Net income for the fourth quarter of 2016 was $127 million, compared with net income of $57 million for the fourth quarter of 2015.

The $74 million increase in net income for 2016 and the $70 million increase for the fourth quarter of 2016 relative to the prior-year periods primarily reflected an increase in gains (after netting certain legal fees and expenses) on settlements relating to the Bank's private-label residential mortgage-backed securities (PLRMBS) litigation and an increase in net fair value gains associated with derivatives, hedged items, and financial instruments carried at fair value.

“During 2016, the Bank performed well for members and the communities they serve,” said Greg Seibly, President and Chief Executive Officer. “Earnings were strong, enhanced by private-label MBS litigation settlements, which resulted in continued improvement in the financial strength of the Bank, supported our ability to offer cost-effective ownership to our members, and increased funding for the Bank’s Affordable Housing Program. We are well-positioned to benefit from the flexibility our healthy balance sheet provides, as we strive to fulfill our housing finance mission by providing essential tools and excellent service to our members and their community partners.”

Net interest income for 2016 was $471 million, down from $477 million for 2015. This decrease was primarily due to a decrease in earnings on mortgage-related assets because of lower average mortgage-related asset balances, partially offset by an increase in earnings on advances because of higher average advance balances.

Net interest income for the fourth quarter of 2016 was $108 million, down from $120 million for the fourth quarter of 2015. This decrease was primarily due to higher dividends paid on mandatory redeemable capital stock (which are classified as interest expense), partially offset by an increase in earnings on advances because of higher average advance balances.

Other income/(loss) for 2016 was income of $485 million, compared with income of $388 million for 2015. The change in other income/(loss) reflected a $51 million increase in gains from settlements relating to the Bank's PLRMBS litigation. In addition, net fair value gains associated with derivatives, hedged items, and financial instruments carried at fair value were $5 million for 2016, compared with net fair value losses of $50 million for 2015. The change in net fair value gains/losses was primarily due to the effects of changes in market interest rates, interest rate spreads, interest rate volatility, and other market factors during the period. The change in other income/(loss) also reflected a partially offsetting impact of expense of $32 million on derivative instruments used in economic hedges, compared with expense of $18 million for 2015. Income/expense on derivative instruments used in economic hedges is generally offset by interest expense/income on the economically hedged assets and liabilities.

Other income/(loss) for the fourth quarter of 2016 was income of $82 million, compared with a loss of $9 million for the fourth quarter of 2015. The change in other income/(loss) reflected a $58 million increase in gains from settlements relating to the Bank's PLRMBS litigation. In addition, net fair value gains associated with derivatives, hedged items, and financial instruments carried at fair value were $31 million for the fourth quarter of 2016, compared with net fair value losses of $6 million for the fourth quarter of 2015. The change in other income/(loss) also reflected a partially offsetting impact of expense of $10 million on derivative instruments used in economic hedges, compared with expense of $4 million for the fourth quarter of 2015.

During 2016, total assets increased $6.2 billion, to $91.9 billion at December 31, 2016, from $85.7 billion at December 31, 2015. Investments increased $8.7 billion, to $41.0 billion at December 31, 2016, from $32.3 billion at December 31, 2015, primarily reflecting an increase in securities purchased under agreements to resell, agency securities, and certificates of deposit. Advances remained relatively stable, decreasing to $49.8 billion at December 31, 2016, from $50.9 billion at December 31, 2015.

Accumulated other comprehensive income increased by $96 million during 2016, to $111 million at December 31, 2016, from $15 million at December 31, 2015, primarily as a result of improvement in the fair value of PLRMBS classified as available-for-sale.

As of December 31, 2016, the Bank was in compliance with all of its regulatory capital requirements. The Bank’s total regulatory capital ratio was 6.4%, exceeding the 4.0% requirement. The Bank had $5.9 billion in permanent capital, exceeding its risk-based capital requirement of $2.2 billion. Total retained earnings as of December 31, 2016, were $3.1 billion.

Today, the Bank’s Board of Directors declared a quarterly cash dividend on the capital stock outstanding during the fourth quarter of 2016 at an annualized rate of 9.08%. The quarterly dividend will total $65 million, including $11 million in dividends on mandatorily redeemable capital stock that will be reflected as interest expense in the first quarter of 2017. The Bank expects to pay the dividend on March 16, 2017.

Financial Highlights (Unaudited) (Dollars in millions)

Selected Balance Sheet Items at Period EndDec. 31, 2016 Dec. 31, 2015 
Total Assets$91,941  $85,698  
Advances 49,845   50,919  
Mortgage Loans Held for Portfolio, Net 826   655  
Investments1 40,986   32,275  
Consolidated Obligations:    
Bonds 50,224   51,827  
Discount Notes 33,506   27,647  
Mandatorily Redeemable Capital Stock 457   488  
Capital Stock - Class B - Putable 2,370   2,253  
Unrestricted Retained Earnings 888   610  
Restricted Retained Earnings 2,168   2,018  
Accumulated Other Comprehensive Income/(Loss) 111   15  
Total Capital 5,537   4,896  
     
Selected Other Data at Period EndDec. 31, 2016 Dec. 31, 2015 
Regulatory Capital Ratio2 6.40 % 6.26 %
 Three Months Ended Twelve Months Ended 
Selected Operating Results for the PeriodDec. 31, 2016 Dec. 31, 2015 Dec. 31, 2016 Dec. 31, 2015 
Net Interest Income$108  $120  $471  $477  
Provision for/(Reversal of) Credit Losses on Mortgage Loans —   1   —   1  
Other Income/(Loss) 82   (9)  485   388  
Other Expense 46   46   158   148  
Affordable Housing Program Assessment 17   7   86   78  
Net Income$127  $57  $712  $638  
         
Selected Other Data for the Period        
Net Interest Margin3 0.46 % 0.55 % 0.52 % 0.57 %
Operating Expenses as a Percent of Average Assets 0.18   0.19   0.16   0.16  
Return on Average Assets 0.54   0.26   0.77   0.76  
Return on Average Equity 9.27   4.66   13.63   11.68  
Annualized Dividend Rate4 22.51   8.79   12.33   12.39  
Average Equity to Average Assets Ratio 5.83   5.54   5.68   6.52  
                 
  1. Investments consist of Federal funds sold, interest-bearing deposits, trading securities, available-for-sale securities, held-to-maturity securities, and securities purchased under agreements to resell.
  2. This ratio is calculated as regulatory capital divided by total assets. Regulatory capital includes retained earnings, Class B capital stock, and mandatorily redeemable capital stock (which is classified as a liability), but excludes accumulated other comprehensive income/(loss). Total regulatory capital as of December 31, 2016, was $5.9 billion.
  3. Net interest margin is net interest income (annualized) divided by average interest-earning assets.
  4. Dividend rates reflect the dividends declared, recorded, and paid during the relevant periods. In the fourth quarter of 2016, the Bank paid a special dividend of 13.57% in addition to a quarterly dividend of 8.94%.

Federal Home Loan Bank of San Francisco  The Federal Home Loan Bank of San Francisco delivers low-cost funding and other services that help member financial institutions make home mortgage loans to people of all income levels and provide credit that supports neighborhoods and communities. The Bank also funds community investment programs that help members create affordable housing and promote community economic development. The Bank’s members are headquartered in Arizona, California, and Nevada and include commercial banks, credit unions, industrial loan companies, savings institutions, insurance companies, and community development financial institutions.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995  This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements related to the Bank’s dividend rates. These statements are based on our current expectations and speak only as of the date hereof. These statements may use forward-looking terms, such as “will” and “expects,” or their negatives or other variations on these terms. The Bank cautions that by their nature, forward-looking statements involve risk or uncertainty and that actual results could differ materially from those expressed or implied in these forward-looking statements or could affect the extent to which a particular objective, projection, estimate, or prediction is realized. These forward-looking statements involve risks and uncertainties including, but not limited to, the application of accounting standards relating to, among other things, the amortization of discounts and premiums on financial assets, financial liabilities, and certain fair value gains and losses; hedge accounting of derivatives and underlying financial instruments; the fair values of financial instruments, including investment securities and derivatives; and other-than-temporary impairment of investment securities. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Contact: Amy Stewart, (415) 616-2605 stewarta@fhlbsf.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 219

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 270

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 238

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 247

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 271

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 177

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against Joint Stock Company Kaspi.kz (KSPI)

Updated Category News Views 149

Understanding the Class Action Lawsuit Against Joint Stock Company Kaspi.kz Levi & Korsinsky, LLP has brought to light an important class action lawsuit concerning the Joint Stock Company Kaspi.kz (NASDAQ: KSPI). This initiative aims to provide legal recourse to investors who may have suffered due to alleged fraudulent activities that negatively impacted the company's...

Continue Reading
Verdafero Enhances Emission Reporting for Hospitality Sector

Updated Category News Views 133

Verdafero Launches New Emissions Reporting Service Verdafero, a prominent player in sustainability solutions, has introduced an expanded service for emissions reporting that now includes comprehensive tracking and analysis of Scope 1, Scope 2, and Scope 3 emissions specifically for the hospitality industry. This innovative offering provides businesses in this sector with...

Continue Reading
Analyst Ratings Spark Interest in GE Vernova and Peers

Updated Category News Views 187

Key Analyst Ratings for Prominent Stocks Wall Street analysts have recently begun covering some noteworthy companies, aiming to provide insights for potential investors. Analyst ratings can spark interest in stocks and guide buying decisions, especially when backed by thorough research. This article highlights the initiation of coverage on five significant stocks,...

Continue Reading
Repertoire Immune Medicines and Lilly Team Up on New Therapies

Updated Category News Views 210

Repertoire Immune Medicines and Eli Lilly Announce Collaboration Repertoire Immune Medicines is excited to announce a significant strategic collaboration with Eli Lilly and Company, focusing on the development of tolerizing therapies to treat various autoimmune diseases. This partnership is set to leverage Repertoire's advanced DECODE™ platform, designed to pioneer T...

Continue Reading
Manhattan Associates Faces Lawsuit Amid Significant Losses

Updated Category News Views 1108

Manhattan Associates Faces Lawsuit Amid Significant Losses A class action lawsuit has emerged against Manhattan Associates, Inc. (NASDAQ: MANH), a prominent player in software solutions for supply chain management and inventory operations. This legal action highlights concerns from investors who have experienced notable financial losses stemming from alleged...

Continue Reading